drugset / Trial / NCT01769638

Safety and Pharmacokinetic Comparison of Sildenafil ODF and FCT Formulations in Healthy Korean Volunteers

NCT01769638

Phase 1 Completed 115 enrolled Seoul Pharma Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This study investigates safety and pharmacokinetic comparison of Seoul Pharma's orally disintegrating film (ODF) formulation of sildenafil (test formulation) and Pfizer's "Viagra® (sildenafil)" Film Coated Tablet (FCT) formulation (reference formulation) in healthy volunteers.

Timeline

Start
2011-09
Primary completion
2011-11
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 50 mg Oral
Subject Sildenafil Unknown 100 mg Oral

Indications

No indication recorded.